baber/WOPTO huggingface dataset:
Patent NZ-333830-A (NZ)
Title: Method for assessing chemosensitivity of a biopsy sample
Inventor: KORNBLITH PAUL L
IPC: A61P17/02
Filed: 1997-07-10
Abstract: A method for preparing a biopsy sample of tissue containing malignant cells for chemosensitivity testing, comprising:  (a) Obtaining a tumor specimen; (b) Mechanically separating said specimen into cohesive multicellular particulates having a size of about 1 mm@3; (c) Growing a tissue culture monolayer from said cohesive multicellular particulates; (d) Inoculating cells from said monolayer into a plurality of segregated sites; (e) Treating said plurality of sites with at least one agent; (f) Examining said plurality of sites; and (g) Assessing chemosensitivity of the cells in said plurality sites.
Patent NZ-335571-A (NZ)
Title: Building structure and method of construction
Inventor: EGGINK HENDRIK JAN
IPC: E04B1/02
Filed: 1999-05-04
Abstract: A method is provided in constructing an exterior perimeter of a building.  A base construction (1) is provided with a plurality of vertical load bearing walls (2) at pre-determined locations on the perimeter of the building.  The pre-determined locations are defined by being the entire perimeter region save for the regions where utility providing means (such as at least windows or doors or openings) are to be provided.  Secured to the upper distal ends of the vertical load bearing walls (2) are lintels (3) to span across the utility providing regions (4).   Within the regions where utility providing means are to be provided, the utility providing means will span the entire region vertically between the base construction and the lintel (3).  The utility providing means are provided to also span the width of each of the regions to abut against the vertical load bearing walls on each side of each region.   A vertical slot is provided within the region extending from the base construction to the lintel (3) where the utility providing means is provided to span the entire vertical distance.
Patent NZ-336842-A (NZ)
Title: Process of making quinoxalinediones to produce antagonistic effect at NMDA receptors
Inventor: STOBIE ALAN
IPC: A61P25/10
Filed: 1998-02-24
Abstract: The compound claimed relates to 2,3(1H,4H)-quinoxalinedione derivatives which are selective antagonists of N-methyl-D-aspartate receptors. More particularly, the compound relates to 5-triazolyl-2,3(1H,4H)-quinoxalinedione derivatives as described in Formula (I) and the preparation of, composition and uses of such derivatives. The compound is useful for events such as stroke, transient ischaemic attack, peri-operative ischaemia, global ischaemia (following cardiac arrest) and traumatic head injury to the brain or spinal cord. In addition, NMDA antagonists may be of use in treating certain chronic neurological disorders such as senile dementia, Parkinson's disease and Alzheimer's disease.
Patent NZ-500696-A (NZ)
Title: Methods and compositions for treating inflammatory bowel disease comprising mycobacterial agents, including macrolides
Inventor: BORODY THOMAS JULIUS
IPC: A61K31/133
Filed: 1998-04-01
Abstract: A composition useful in treating inflammatory bowel disease.  The composition comprises combinations of three or more anti-atypical mycobacterial agents effective against the atypical mycobacterial strains.  At least one of the anti-atypical mycobacterial agents is a macrolide.
Patent NZ-501414-A (NZ)
Title: Pentaerythritol derivatives, the production and uses thereof and intermediate products for the synthesis of active agents for treating heart/circulation and vascular illnesses
Inventor: KONIG GERD
IPC: A61P9/00
Filed: 1998-06-11
Abstract: Synthesis and use of compounds derived from pentaerythritol of formulas (I), (III), (V) and (VI) of NZ Patent Specification 514312, which can be used as pharmaceutically active substances for the treatment of cardiac and circulatory diseases are described. Compounds of formula (I):  (O2NOCH2)mC(CH2OH)n(CH2COR1)p In which R1 represents a group of the formula (II), in which R2 represents a C1 to C20 alkyl group; and m to p are integers, where m+n+o+p=4, m>=1, and o and/or p>=1. Compounds of formula (III):  (O2NOCH2)mC(CH2OH)n (CH2COR3)o(COR3)p in which R3 represents a group of the formula (IV) in which R2 represents a C1 to C20 alkyl group; and m to p are integers, where m+n+o+p=4, m>=1, and o and/or p>=1. Compounds of formula (V) in which R2 represents a C1 to C20 alkyl group; and R4 represents a C1 to C6 alkanoyl group, salicyloyl or acetylsalicyloyl. Compounds of formula (VI):  (O2NOCH2)mC(CH2OH)n(CH2COR5)o (COR5)p in which R5 is (2-carboxyphenyl)oxy or (2-alkoxycarbonylphenyl)oxy and m to p are integers, and: m+n+o+p=4, m>=1, and o and/or p>=1 and their therapeutically acceptable salts.
Patent NZ-503014-A (NZ)
Title: Tricycle with pedals rotating respective rear wheels independently, each via a respective chain, spring and ratchet drive to wheel
Inventor: CHAO YU-CHAO
IPC: B62M1/00
Filed: 2000-02-24
Abstract: A user's feet press pedals 33 down so as to rotate rear wheels 20. This extends springs 33 which raise pedals 33 and rotate sprockets 31. This is stated to provide beneficial exercise, especially for the young and elderly.
Patent NZ-505943-A (NZ)
Title: Methods for increasing the ratio of docosahexaenoic acid to eicosapentaenoic acid in the live prey of larval fish
Inventor: PLACE ALLEN R
IPC: A23K1/18
Filed: 1999-01-21
Abstract: A method of enriching fish food and live larval fish prey, especially Artemia nauplii and rotifers, with essentially highly unsaturated fatty acids, vitamins, amino acids, carotenoids and pigments. The live prey are allowed to ingest/adsorb dry soap powders of highly unsaturated fatty acids obtained from the waste stream of marine algae oil extraction. The live prey can be highly enriched in docosahexaenoic acid obtaining ratios of docosahexaenoic acid to eicosapentaenoic acid greater than about 2.0 to 1.0.
Patent NZ-507160-A (NZ)
Title: Memory management in a receiver/decoder where the memory has a first-in-first out (FIFO) section
Inventor: DECLERCK CHRISTOPHE
IPC: G06F5/14
Filed: 1999-03-29
Abstract: A memory management module (11) particularly for use in a receiver/decoder for a broadcast digital television system in which received signals are passed through a receiver to the receiver/decoder and thence to a television set.  The module (11) couples incoming messages from port units (10) to application modules (12). A memory (13) coupled to the unit (11) has a buffer area (13-B) and a FIFO area (13-F), controlled by a buffer controller/handler (14-B) and a FIFO controller/handler (14-F) respectively.  An incoming message can be passed into a buffer, and retrieved from the buffer by the application to which it is directed; two different operating modes are available for this.  Alternatively, such a message can be passed to a FIFO; the FIFO handler acts as a low-level application which can pass the message on to a high-level application without that application having to take any action and without having to wait for the full message to be received. Messages passing through the FIFO are may be combined into an MPEG signal stream.
Patent NZ-508066-A (NZ)
Title: Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
Inventor: MOMOSE YU
IPC: A61K31/427
Filed: 1999-05-10
Abstract: The compound of formula (I) wherein: R1  is  an  optionally substituted hydrocarbon group  or  an optionally substituted heterocyclic group X  is a bond, -CO-, -CH(OH)- or group represented by -NR6  - wherein  R6  is a hydrogen atom or an optionally substituted alkyl group; n is an integer of 1 to 3; Y  is  an oxygen atom, a sulfur atom, -SO-, -SO2- or a group represented  by -NR7- wherein R7 is a hydrogen  atom  or  an optionally substituted alkyl group; Ring A is a benzene ring optionally having additional one to three substituents; p is an integer of 1 to 8; R2 is a hydrogen atom, au optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; q is an integer of 0 to 6; m is 0 or 1; R3  is a hydroxy group, OR8 (R8 is an optionally substituted hydrocarbon  group.) or NR9R10 (R9 and R10 are the  same  or different  groups which are selected from a  hydrogen  atom, an  optionally substituted hydrocarbon group, an  optionally substituted    heterocyclic   group   and   an    optionally substituted  acyl  group or R9 and R10 combine  together  to form a ring); R4  and  R5  are  the  same or different  groups  which  are selected  from a hydrogen atom and an optionally substituted hydrocarbon group wherein R4 may form a ring with R2;  or  a salt thereof Provided that when R1 is ethoxymethyl, a C1-3 alkyl,  phenyl or  p-methoxyphenyl and q=m=0, R3 is R9R10 and provided that O-[2-chloro-4-(2-quinolylmethoxy)phenyl   methyl]oxime    of methyl          pyruvate         and         [2-chloro-4-(2- quinolylmethoxy)phenylmethyl-2-iminoxypropionic   acid   are excluded. The  pharmaceutical composition comprising the  compound  of formula   (I)  is  useful  in  the  treatment  of   diabetes mellitus,    hyperlipemia,   impaired   glucose   tolerance, inflammatory disease and arteriosclerosis. The compound  can also be used for controlling retinoid-related receptors,  is a  ligand of peroxisome proliferator-activated receptors,  a retinoid  X  receptor  ligand  and  an  insulin  sensitivity improving and enhancing agent.
Patent NZ-510068-A (NZ)
Title: Method for improving the operation of a flotation cell line
Inventor: NIITTI TIMO
IPC: B03B11/00
Filed: 1999-09-13
Abstract: Improved  operation  of a flotation  cell  line,  said flotation  cell line comprising several flotation cells  (1, 2,  3,  4,  5) that are connected by means of liquid  stream flow.  At  least  part  of  the  material  flotated  in  the flotation cell line is conducted past the cell (1)  that  is located first in the flotation cell line, when seen  in  the flowing direction (7) of the flotatable material.
Patent NZ-510572-A (NZ)
Title: Use of a combination of angiotensin converting enzyme inhibitor, aldosterone antagonist and diuretic for treating cardiovascular diseases
Inventor: MACLAUGHLAN TODD E
IPC: A61P9/00
Filed: 1996-02-09
Abstract: An angiotensin converting enzyme inhibitor a, a diuretic agent and an aldosterone receptor antagonist are used to treat cardiovascular diseases in a subject afflicted with or susceptible to multiple cardiovascular disorders.  The amount of aldosterone receptor antagonist present is therapeutically effective to antagonize aldosterone but insufficient to induce an adverse side effect and to provide a daily dosage range of 5-22.5 mg per dose.
Patent NZ-510718-A (NZ)
Title: Method for surface treating grains comprising heating the grain to from alpha starch near the surface of the grain
Inventor: ISOGAYA KEIICHI
IPC: A23P30/00
Filed: 2001-03-23
Abstract: A surface treatment method for polished rice, barley, Japanese millet, foxtail millet, adlay, or other grains, or kneaded and solidified starch.  The method involves applying an air stream with a humidity of 50% or more and a temperature of 85 to 300oC to a polished grain or a granular material obtained by kneading and solidifying a starch, to heat a surface layer portion to convert the starch in the heated portion into a paste state and make the starch into an alpha state.  The surface portion is then cooled so as to form a fine layer of alpha starch in the surface portion. The surface treatment is carried out by an apparatus that comprises a heating tank, a cooling conveyor and a machine adapted to generate an air stream with a humidity of 50% or more and a temperature of 85 to 300oC and adapted to apply the air stream to a raw granular material so as to forma fine layer of an alpha starch in a surface portion.
Patent NZ-514346-A (NZ)
Title: Modulation of an enzyme capable of polynucleotide synthesis in order to manipulate a predetermined polynucleotide sequence
Inventor: DENSHAM DANIEL HENRY
IPC: C07K14/215
Filed: 2000-04-06
Abstract: A method for polynucleotide synthesis, which comprises the following steps: (i)    Reacting   an   enzyme  capable   of   polynucleotide synthesis,  e.g.  a polymerase, with a nucleotide  substrate under conditions suitable for enzyme activity; and (ii)  Modulating the conformation of the enzyme by  applying electromagnetic radiation, surface plasmon  resonance  or  a laser to allow incorporation of a predetermined nucleotide. Moreover  a method wherein the conformation is modulated  by applied radiation or wherein the enzyme is fixed within  the field  of  applied radiation or a method wherein the  enzyme is   immobilised  on  a  solid  support  or  is  a  terminal deoxynucleotidyl transferase.
Patent NZ-514439-A (NZ)
Title: Waterproofed vapor-permeable sole for shoes
Inventor: POLEGATO MORETTI MARIO
IPC: A43B/
Filed: 2001-01-15
Abstract: A waterproofed and vapor-permeable sole for shoes, comprising a tread which is made of leather or similar material and is at least partially covered in an upward region by a membrane made of a material which is permeable to vapor and impermeable to water and is sealed in its peripheral regions with respect to the tread. The tread has through holes in which inserts made of plastic material such as rubber or the like are assembled hermetically, the inserts in turn having through holes.
Patent NZ-514609-A (NZ)
Title: Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
Inventor: EHLERS MARIO R W
IPC: A61K38/26
Filed: 2000-05-01
Abstract: Disclosed is the use of a compound that activates a receptor for glucagons-like peptide-1 or GLP-1 in medical treatment following acute stroke or hemorrhage. Preferably the compound is GLP-1, which can preferably be administered intravenously. It provides a means for optimizing insulin secretion, increasing brain anabolism, enhancing insulin effectiveness by suppressing glucagon, and maintaining euglycemia or mild hypoglycemia with no risk of severe hypoglycemia.
Patent NZ-514952-A (NZ)
Title: Composite closure cap having two parts, the functional part and the decorative part
Inventor: GRANGER JACQUES
IPC: B65D41/62
Filed: 2000-04-17
Abstract: The invention concerns a cap (1) comprising a head and a skirt and is characterised in that it comprises two assembled parts: a) an inner part (3) comprising a head said to be internal (30) and a skirt said to be inner (31), forming an axis of rotation ensuring the so-called technical functions of said cap; b) an external part (4) providing all or part of the decorative function of said cap (1), so as to modify at will the appearance of said cap (1) without modifying its technical functions.
Patent NZ-515852-A (NZ)
Title: Products and methods for single parameter and multiparameter phenotyping of cells
Inventor: PANKOWSKY DAN A
IPC: G01N33/569
Filed: 2000-05-03
Abstract: A method of single parameter and multiparameter characterizing of cells, particularly immunophenotyping of cells, is provided. The method preferably uses antibody coated microspheres which are adapted to bind to specific types of cells. One or more sets of coated microspheres are added simultaneously or sequentially to a suspension of cells and bind the cells they are adapted to bind. Cells may bind to one or more microspheres. The suspension is then filtered to trap bead-cell complexes. The complexes are preferably stained and then examined to characterize the cells, preferably the cells bound to the microspheres. A kit and apparatus for performing the method are also provided.
Patent NZ-516393-A (NZ)
Title: Low-carbon steels of enhanced mechanical and corrosion properties with heating and cooling to achieve laths of martensite alternating with films of retained austenite, and no carbides
Inventor: THOMAS GARETH
IPC: C21D1/22
Filed: 2000-03-28
Abstract: Alloy steels that combine high strength and toughness with high corrosion resistance are achieved by a dislocated lath microstructure, in which dislocated martensite laths that are substantially free of twinning alternate with thin films of retained austenite, with an absence of autotempered carbides, nitrides and carbonitrides in both the dislocated martensite laths and the retained austenite films. This microstructure is achieved by selecting an alloy composition whose martensite start temperature is 350 ·C or greater, and by selecting a cooling regime from the austenite phase through the martensite transition region that avoids regions in which autotempering occurs.
Patent NZ-520871-A (NZ)
Title: Reinforced bag-in-box container
Inventor: HOLLAND CRAIG
IPC: B65D5/02
Filed: 2000-10-06
Abstract: A container formed from corrugated board or similar packaging materials, including a base panel (1), a top panel (2), side panels (3 and 4) and end panels (5 and 6) which together form a closed container, the side panels having extension portions (7 and 8) which are folded and secured to form double thickness end flaps which are foldable inside the end panels, the extension portions (7, 8) of at least one end of the side panels having a further portion (13, 14) which is secured to reinforce each side panel.
Patent NZ-523013-A (NZ)
Title: Ambient temperature curing coating composition containing alkoxysilyl-functional acrylic terpolymeracrylic polymer
Inventor: NIXON STEVE ALISTER
IPC: C09D201/10
Filed: 2001-06-14
Abstract: Ambient temperature curing coating composition comprising - a polysiloxane having the formula (as pictured) wherein each R1 is selected from the group consisting of alkyl, aryl, and alkoxy groups having up to six carbon atoms, reactive glycidoxy groups, and Osi(OR3)3 groups, wherein each R3 independently has the same meaning as R1, each R2 is selected from the group consisting of hydrogen and alkyl and aryl groups having up to six carbon atoms, and wherein n is selected so that the molecular weight of the poysiloxanes is in the range of from 500 to about 2,000, and - an alkoxysilyl-functional acrylic polymer - optionally water as a curing agent, wherein said coating composition comprises more than 70% by weight solids; also disclosed is the preparation of said composition; and the use of said composition as a finish coating and/or primer coating.
Patent NZ-526230-A (NZ)
Title: Anchorage
Inventor: BIRSS DAVID
IPC: E04H15/62
Filed: 2001-11-15
Abstract: An anchorage such as a tent peg comprises a hook (2) for attaching a guy rope (6), a tapered end (1), two or more spikes (4) remote from the tapered end (1) for inserting into the ground and a generally flat body (5) between the spikes and the tapered end. The flat body is designed to be easily stamped into the ground by foot and to lie flush with the ground during use. A finger hole may be provided for easy removal of the anchorage from the ground after use.
Patent NZ-527322-A (NZ)
Title: EHEC cell culture supernatant vaccine
Inventor: FINLAY BRETT
IPC: A61K39/00
Filed: 2002-01-03
Abstract: Described is a vaccine composition comprising an enterohemorrhagic Escherichia coli (EHEC) cell culture supernatant and an immunological adjuvant. The composition elicits an immune response against a secreted EHEC antigen.
Patent NZ-527678-A (NZ)
Title: Dairy product and process
Inventor: LOWE EDWIN
IPC: A23C9/13
Filed: 2003-08-19
Abstract: A process for preparing a yoghurt comprising the following steps: a) adding a measured amount of whey protein to a milk and calculating the casein: whey protein weight ratio in the resulting mixture, b) determining the optimum pH of the milk at the casein: whey protein ratio calculated in step a) for preparing a yoghurt having a desired gel strength, c) adjusting the pH of the milk from step a) to the optimum pH, determined in step b), d) heating the milk from step c) to a temperature of from 70°C to its boiling point for a time of 0.1 seconds to 60 minutes, and e) acidifying the milk stream from step d) using a microorganism treatment or chemical acidification to prepare a yoghurt.
Patent NZ-530316-A (NZ)
Title: Novel immunomodulating compounds
Inventor: BJORK PER AXEL
IPC: C07D495/04
Filed: 2002-07-02
Abstract: A compound of formula I wherein: X represents a bond or a group selected from substituted or unsubstituted alkyl, NH-C(O)-alkyl, NH-C(O)-CH2-O-CH2 or C(O)-NH-(amino acid residue); Y represents NR4, O or S; R1 represents H, halo, CF3, lower alkyl or lower alkoxy; R2 and R4 represents independently H or lower alkyl; and R3 represents H, halo, lower alkyl or lower alkoxy; Wherein halo represents F, Cl or Br; lower alkyl represents saturated or unsaturated, straight, branched or cyclic alkyl froups having 1-6 carbon atoms; and lower alkoxy represents saturated or unsaturated, straight, branched or cyclic alkoxy groups having 1-6 carbon atoms, with the proviso that R2 is not H, when X is a bond, Y is NH and R3 is H. Also disclosed is a pharmaceutical composition comprising said compound, for the treatment of medical conditions from the group of: rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus, eruthematosis and psoriasis.
Patent NZ-532134-A (NZ)
Title: A display device
Inventor: POINTON RUSSELL
IPC: G09F21/02
Filed: 2002-09-06
Abstract: A display device has a planar element (1) having a face adapted to carry for display purposes an image or images, the planar element comprising a tab formed of a flexible or resilient material and being adapted to be fastened by a securing means (2) on a leg of a human body so that the face is visible. The material of the planar element is sufficiently stiff to ensure that the face remains substantially flat enough for the images to remain viewable during normal movement of the body and normal external forces. The securing means comprises a substantially non-resilient tie or a resilient band. The planar element may be double sided. An additional tie or securing means may be provided. The tab may be perfumed.
Patent NZ-536031-A (NZ)
Title: Method and apparatus for storing and retrieving items
Inventor: GOLDSCHLAGER LESLIE MICHAEL
Filed: 2003-03-24
Abstract: A method of storing and retrieving items is disclosed. The method includes: (a) grouping the items into one or more groups of items; (b) recording the content of each group; (c) comparing a batch of orders for items with the recorded content of the groups in order to locate a matching group that matches the batch or orders; and (d) retrieving the matching group in order to fill the batch of orders.
Patent NZ-538156-A (NZ)
Title: Use of and some novel imidazopyridines
Inventor: JOHANSSON HENRIK
IPC: A61K31/437
Filed: 2003-08-13
Abstract: A compound of formula (Ia) is disclosed which is described to be used in the manufacture of a medicament for the treatment of allergic, autoimmune, inflammatory and proliferative diseases or conditions in which inhibition of inducible T cell kinase (Itk) activity is beneficial is disclosed, wherein: R3 represents halogen, C 1 to 3 alkyl or C 1 to 3 alkoxy; R10 represents H; Ar represents phenyl, a 5- or 6-membered heteroaromatic ring or an indole ring; said hetero-aromatic ring incorporating 1 to 3 heteroatoms independently selected from O, N and S; m represents an integer 1 or 2; when m represents 1, R1 represents (CH2)nNR4R5 and n represents an integer 0 or 1; when m represents 2, one R1 represents chloro or OMe and the other R1 represents (CH2)nNR4R5 and n represents an integer 0 or 1; and R4 and R5 are as defined in the specification.
Patent NZ-540124-A (NZ)
Title: A carton
Inventor: BLAIR ALEXANDER GRANT
IPC: B65D25/38
Filed: 2002-08-30
Abstract: A blank to define a container where there is a capability of being opened to define an opening to allow the dispensing of contents and a tube provided internally of the erected container which has the capability of assembling the container contents adjacent an entrance way for the tube and to dispense an amount via the tube out of the outlet. (62) Divided out of 521104